We have observed
8 EP applications
Sean Matthew Alexander
has served for within the last five+ years.
(We consider all applications which have an EP A1 publication dated after
December 16, 2012).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
SALMONID ALPHAVIRUS AND USES THEREOF
FLAVIVIRUS ASSOCIATED WITH THEILER'S DISEASE
INTERACTIONS OF BETANODAVIRUSES IN INFECTION
METHODS FOR PREPARING INACTIVATED ROTAVIRUS
MODIFIED ANIMAL ERYTHROPOIETIN POLYPEPTIDES AND THEIR USES
MODIFIED BOVINE G-CSF POLYPEPTIDES AND THEIR USES
METHODS FOR TREATING KIDNEY DISORDERS